Twist Bioscience Corp
NASDAQ:TWST

  • LAST PRICE
    40.9600
  • TODAY'S CHANGE (%)
    -0.4700 (-1.1344%)
  • Bid / Lots
    40.9100/ 8
  • Ask / Lots
    41.1200/ 8
  • Open / Previous Close
    41.7200 / 41.4300
  • Day Range
    40.4501
    41.7585
  • 52 Week Range
    23.0000
    60.9000
  • Volume
    147,469

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
TWST
Twist Bioscience Corp
2.4B
-11.4x
---
ARWR
Arrowhead Pharmaceuticals Inc
2.4B
-4.1x
---
CPRX
Catalyst Pharmaceuticals Inc
2.5B
18.0x
---
ZLAB
Zai Lab Ltd
2.7B
-9.4x
---
GMAB
Genmab A/S
13.7B
20.3x
+22.71%
GLPG
Galapagos NV
1.8B
-28.0x
---
As of 2024-11-19

Company Information

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.

Contact Information

Headquarters
681 Gateway Blvd.SOUTH SAN FRANCISCO, CA, United States 94080
Phone
408-410-0105
Fax
302-531-3150

Executives

Chairman of the Board, Chief Executive Officer
Emily Leproust
President, Chief Operating Officer
Patrick Finn
Chief Financial Officer
Adam Laponis
Senior Vice President, General Counsel, Secretary and Chief Ethics and Compliance Officer
Dennis Cho
Senior Vice President - Advanced Development, General Manager of Data Storage and Director
William Banyai

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$2.4B
Revenue (TTM)
$313.0M
Shares Outstanding
58.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.78
EPS
$-3.60
Book Value
$8.07
P/E Ratio
-11.4x
Price/Sales (TTM)
7.8
Price/Cash Flow (TTM)
---
Operating Margin
-70.56%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.